| Document |
Document Title |
|
WO/2020/193649A1 |
The invention relates to therapeutic applications, in particular to the treatment or prevention of diseases related to a protozoa infection (malaria, leishmaniasis) or a fungal infection, of 1,2-dioxolane-3,5-disubstituted compounds, and...
|
|
WO/2020/185695A1 |
Disclosed herein are embodiments of a compound having a Formula I, or a salt, solvate, N-oxide, prodrug, diastereomer or enantiomer thereof. Also disclosed are derivative compounds made from the compound of Formula I. Certain derivative ...
|
|
WO/2020/174271A1 |
The present disclosure provides a process for preparing an aryl ketone of Formula I, comprising reacting a substituted benzene of Formula II with a carboxylic acid of formula IIIa and/or a carboxylic anhydride of formula IIIb in presence...
|
|
WO/2020/169035A1 |
The present invention relates to a method for preparing alkylene carbonate from alkylene oxide and carbon dioxide. The technical solution thereof is: raw materials containing the alkylene oxide and the carbon dioxide are in contact with ...
|
|
WO/2020/169012A1 |
The present invention relates to the field of medicine, and disclosed thereby are a method for synthesizing a pharmaceutical intermediate, as well as a use thereof; specifically, the present invention relates to improvements to a method ...
|
|
WO/2020/169032A1 |
The present invention relates to a method for preparing an alkylene carbonate from epoxyalkane and carbon dioxide. A raw material containing epoxyalkane and carbon dioxide is made to contact a catalyst for reaction to generate an alkylen...
|
|
WO/2020/166632A1 |
The present disclosure provides: a method which is capable of producing a fluorolactone compound from hexafluoropropylene oxide or the like by a single step; and the like.　The present disclosure relates to a method for producing a comp...
|
|
WO/2020/162630A1 |
The purpose of the present disclosure is to provide a method for producing an organic compound, etc. Said purpose is solved by a method for producing a compound represented by formula (1). [In the formula, X represents -O-, an imino grou...
|
|
WO/2020/146568A1 |
A method for the synthesis of diazabicyclo[6.2.0]decane compounds is provided. The synthesis proceeds by stereoselective synthesis of a chiral lactone followed by azetidine formation via a series of chemoselective reactions. Bicyclizatio...
|
|
WO/2020/141562A1 |
The present invention relates to novel crystalline forms of 4-{8-amino-3-[(2S) -1- (but-2-ynoyl) pyrrolidin-2-yl] imidazo [1,5-a] pyrazin-1-yl)}-N-(pyridine-2-yl) benzamide represented by the following structural formula-1, which is refe...
|
|
WO/2020/136330A1 |
The invention relates to a compound of formula (I) capable of being grafted onto a polymer for the purpose of enabling the polymers to be functionalized after polymerization. Formula (I) in which - Q is a dipole comprising at least one n...
|
|
WO/2020/138387A1 |
Provided is a method for producing an organic compound, the method making it possible to ensure an adequate reaction time and obtain a target substance at a high yield even in an organic reaction that requires a relatively long time to c...
|
|
WO/2020/138011A1 |
The present invention addresses the problem of providing a compound which has a retinoic acid receptor agonist activity and is useful as a medicine that is capable of treating and/or preventing a retinal degenerative disease. The compoun...
|
|
WO/2020/130122A1 |
Provided is a method for stabilizing perfluoro(2-methylene-4-methyl-1,3-dioxolane) comprising incorporating, in a perfluoro(2-methylene-4-methyl-1,3-dioxolane)-containing composition, at least one selected from the group consisting of hy...
|
|
WO/2020/122341A1 |
The present invention relates to a novel cinnamic acid derivative having an excellent antibacterial effect and an antibacterial composition comprising same. Specifically, the present invention relates to an antibacterial composition comp...
|
|
WO/2020/122908A1 |
An electrochromic medium for use in an electro-optic device comprises a solvent comprising at least one low-volatile organic electrolyte solvent based on a cyclic carbonate ester; an anodic electroactive material; and a cathodic electroa...
|
|
WO/2020/100977A1 |
The purpose of the present invention is to provide a method for safely and efficiently producing a carbonate derivative even when a base is not used. This method for producing a carbonate derivative includes a step in which a composition...
|
|
WO/2020/095915A1 |
Provided is a perfluoro(2-methylene-4-methyl-1,3-dioxolane) production method containing at least steps (1) to (3) below. (1) Causing at least any one of perfluoro(2,4-dimethyl-2-fluoroformyl-1,3-dioxolane) and a hydrolysis product there...
|
|
WO/2020/089274A1 |
The present invention refers to alkoxybenzaldehyde derivatives and precursors thereof. The invention further refers to perfume compositions and fragranced article comprising them.
|
|
WO/2020/090700A1 |
The present invention addresses the problem of providing an ynone compound useful for the inducement of an endoplasmic reticulum stress response. The problem can be solved by an ynone compound represented by formula (1) [in the formula, ...
|
|
WO/2020/086728A1 |
In one aspect, compounds of Formula A, or a pharmaceutically acceptable salt thereof, are featured (Formula A) or a pharmaceutically acceptable salt thereof, wherein the variables shown in Formula A can be as defined anywhere herein.
|
|
WO/2020/086864A1 |
Described are positive allosteric modulators of muscarinic acetylcholine receptor M1 (mAChR M1), pharmaceutical compositions including the compounds, and methods of using the compounds and compositions for treating neurological disorders...
|
|
WO/2020/081836A1 |
The present disclosure provides compounds and compositions capable of extending lifespan, and methods of use thereof.
|
|
WO/2020/070759A1 |
The present invention relates to a process for preparing 2,2-difluoro-1,3-benzodioxole. The process comprises a step of reacting 1,3-benzodioxole with chlorine in benzotrifluoride in the present of a radical initiator. The present invent...
|
|
WO/2020/060499A1 |
The present invention provides a catalyst system for producing cyclic carbonates comprising: a pre-catalyst selected from the compound having formula B1XZ; a compound having formula (I) wherein: X and Y each independently represent halid...
|
|
WO/2020/060498A1 |
The present invention provides a catalyst system for producing cyclic carbonates from carbon dioxide (CO2) and epoxide-based compounds comprising: a pre-catalyst selected from the compound having the formula BiXz; and a co-catalyst selec...
|
|
WO/2020/053353A1 |
The invention relates to a method for producing S-arylthiocarbamates of general formula (I) by means of an electrochemically induced rearrangement of an O-arylthiocarbamate of general formula (II).
|
|
WO/2020/056090A1 |
Disclosed are compounds of Formulae 1 and 10 including all geometric and stereoisomers, tautomers, N oxides, and salts thereof, wherein E, L, J, A, T, R1, R2a, R2b, X, Y, R6a, R6b and R29 are as defined in the disclosure. Also disclosed ...
|
|
WO/2020/055725A1 |
Disclosed herein are novel methods of treating pain in a patient in need thereof by providing to the patient a selective dopamine D3 receptor antagonist/partial agonist which when used with an opioid analgesic, can mitigate the developme...
|
|
WO/2020/050249A1 |
Provided is a method for producing a trifluoropyruvate fluoride dimer, said method comprising a reaction step for reacting hexafluoropropylene oxide with an aldehyde.
|
|
WO/2020/042079A1 |
Disclosed a process for preparing a solketal amine via direct amination. It is possible to obtain solketal amines by very simple procedure with desired characteristics such as simplicity, inexpensiveness, high yield and conversion, as we...
|
|
WO/2020/037652A1 |
Some organoplatinum compounds have been synthesized. These organoplatinum compounds are designed to be human Topoisomerase II-targeting drugs.
|
|
WO/2020/037408A1 |
The present disclosure relates to a cannabis-infused product comprising a cannabinoid profile including one or more cannabinoid, a first composition for controlling onset of the cannabinoid profile and a second composition for controllin...
|
|
WO/2020/032080A1 |
Provided is a compound represented by general formula (I), or a salt thereof. (In the formula, X1, X2, X3 and X4 are a hydrogen atom, a C1-9 alkyl group, or a C3-9 unsaturated hydrocarbon group which has 1-4 triple bonds between carbon a...
|
|
WO/2020/028606A1 |
In one aspect, the present invention encompasses compositions of sustainable polycarbonate polymers, methods of producing such polymers, and methods for evaluating whether certain constituents of a polymer chain are derived from biomass ...
|
|
WO/2020/025502A1 |
The present invention relates to the field of chemical components for electrolyte compositions which are useful in electrochemical cells, such as lithium-ion batteries. More specifically, the invention provides new components and their c...
|
|
WO/2020/026273A1 |
The present invention related to novel crystalline forms of (1S, 2S, 3S, 4R, 5S)-5-(4-chloro-3-(4-ethoxybenzyl) phenyl)-1-(hydroxymethyl)-6,8-dioxabicyclo [3.2.1] octane-2,3,4-triol free base of formula (I) and process for their preparat...
|
|
WO/2020/004185A1 |
Provided is a cyclic-carbonate-substituted propylcatechol having a structure represented by formula (1), wherein R1 and R2 are each independently a hydrogen atom or an organic group. R1 is preferably an organic group represented by formu...
|
|
WO/2020/006177A1 |
Disclosed herein are small molecule Vascular Adhesion Protein- 1 (VAP-1) modulator compositions, pharmaceutical compositions, the use and preparation thereof.
|
|
WO/2019/238548A1 |
The invention relates to a process for preparing cyclic organic carbonates, characterized in that an epoxide is initially charged in the presence of CO2 and then a catalyst is added.
|
|
WO/2019/233474A1 |
The present disclosure relates to compounds with antiviral activity, methods for the preparation ofsuch compounds, and their use to inhibit viral nucleoprotein activity, viral transcription, replication, and assembly into the newly forme...
|
|
WO/2019/229384A1 |
The invention relates to a monoethylenically unsaturated monomer of formula (I), and to the use thereof for producing a polymer. The invention also relates to the polymer obtained by polymerising said monomer, and to the use thereof in a...
|
|
WO/2019/219468A1 |
The present invention relates to a process for preparing dioxolane by reacting ethylene glycol with an aqueous solution of formaldehyde in the presence of an acid catalyst. The raw product comprising water, dioxolane and methanol is fed ...
|
|
WO/2019/219475A1 |
The present invention relates to a process for preparing dioxolane by reacting ethylene glycol with an aqueous solution of formaldehyde in the presence of an acid catalyst. The raw product comprising water, dioxolane and methanol is fed ...
|
|
WO/2019/219469A1 |
The present invention relates to a compound of formula (I) wherein R1 is hydrogen or an organic radical having from 1 to 100 carbon atoms, R2, R3 independently of one another are hydrogen or an organic radical having from 1 to 100 carbon...
|
|
WO/2019/201842A1 |
The present invention relates to a new method for the esterification of N-acylated amino acids containing an acid-labile ketone protective group under alkaline conditions without the use of a polar aprotic solvent, by esterifying the N-a...
|
|
WO/2019/197231A1 |
The present invention relates to new methods for producing cis-alkoxy substituted spirocyclic 1-H-pyrrolidine-2,4-dione derivatives and new intermediates or starting compounds that are used in the method according to the invention.
|
|
WO/2019/185877A1 |
The invention relates to a method for the preparation of a 4,5-dihydroxyisoleucine derivative comprising the steps of asymmetric Claisen rearrangement of a Z-aminocrotyl-glycin ester and subsequent kinetic resolution of the product diast...
|
|
WO/2019/175713A1 |
The present invention relates to the new catechol molecules and their use as inhibitors to P450 related metabolic pathways. The invention further relates to a method of controlling crop pests and/ or non-crop pests that are resistant to ...
|
|
WO/2019/175712A1 |
The present invention relates to a use of compounds of the formula (I) as Glutathione-S-transferase inhibitor. The invention further relates to a method of controlling crop pests and/or non-crop pests that are resistant to one or more in...
|
